Co-Authors
This is a "connection" page, showing publications co-authored by Igor C. Almeida and Katja Michael.
Connection Strength
2.436
-
Montoya AL, Gil ER, Vinales I, Estevao IL, Taboada P, Torrico MC, Torrico F, Marco JD, Almeida IC, Michael K. Big is not better: Comparing two alpha-Gal-bearing glycotopes in neoglycoproteins as biomarkers for Leishmania (Viannia) braziliensis infection. Carbohydr Res. 2024 Feb; 536:109015.
Score: 0.247
-
Baily PT, Del Castillo HP, Vinales I, Urbay JEM, Paez A, Weaver MR, Iturralde R, Estevao IL, Jankuru SR, Almeida IC, Li C, Dirk CW, Michael K. Synthesis and Photoreactivity of 7-Nitroindoline-S-thiocarbamates. ACS Omega. 2023 Mar 14; 8(10):9486-9498.
Score: 0.233
-
Viana SM, Montoya AL, Carvalho AM, de Mendon?a BS, Portillo S, Olivas JJ, Karimi NH, Estevao IL, Ortega-Rodriguez U, Carvalho EM, Dutra WO, Maldonaldo RA, Michael K, de Oliveira CI, Almeida IC. Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins. Emerg Microbes Infect. 2022 Dec; 11(1):2147-2159.
Score: 0.229
-
Montoya AL, Carvajal EG, Ortega-Rodriguez U, Estevao IL, Ashmus RA, Jankuru SR, Portillo S, Ellis CC, Knight CD, Alonso-Padilla J, Izquierdo L, Pinazo MJ, Gascon J, Suarez V, Watts DM, Malo IR, Ramsey JM, Alarc?n De Noya B, Noya O, Almeida IC, Michael K. A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease. Molecules. 2022 Sep 05; 27(17).
Score: 0.225
-
Montoya AL, Gil ER, Heydemann EL, Estevao IL, Luna BE, Ellis CC, Jankuru SR, Alarc?n de Noya B, Noya O, Zago MP, Almeida IC, Michael K. Specific Recognition of ?-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients. Molecules. 2022 Jan 09; 27(2).
Score: 0.215
-
Alonso-Vega C, Urbina JA, Sanz S, Pinazo MJ, Pinto JJ, Gonzalez VR, Rojas G, Ortiz L, Garcia W, Lozano D, Soy D, Maldonado RA, Nagarkatti R, Debrabant A, Schijman A, Thomas MC, L?pez MC, Michael K, Ribeiro I, Gascon J, Torrico F, Almeida IC. New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ Open. 2021 12 31; 11(12):e052897.
Score: 0.215
-
Montoya AL, Austin VM, Portillo S, Vinales I, Ashmus RA, Estevao I, Jankuru SR, Alraey Y, Al-Salem WS, Acosta-Serrano ?, Almeida IC, Michael K. Reversed Immunoglycomics Identifies a-Galactosyl-Bearing Glycotopes Specific for Leishmania major Infection. JACS Au. 2021 Aug 23; 1(8):1275-1287.
Score: 0.208
-
Portillo S, Zepeda BG, Iniguez E, Olivas JJ, Karimi NH, Moreira OC, Marques AF, Michael K, Maldonado RA, Almeida IC. A prophylactic a-Gal-based glycovaccine effectively protects against murine acute Chagas disease. NPJ Vaccines. 2019; 4:13.
Score: 0.177
-
Ortega-Rodriguez U, Portillo S, Ashmus RA, Duran JA, Schocker NS, Iniguez E, Montoya AL, Zepeda BG, Olivas JJ, Karimi NH, Alonso-Padilla J, Izquierdo L, Pinazo MJ, de Noya BA, Noya O, Maldonado RA, Torrico F, Gascon J, Michael K, Almeida IC. Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of a-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease. Methods Mol Biol. 2019; 1955:287-308.
Score: 0.175
-
Schocker NS, Portillo S, Brito CR, Marques AF, Almeida IC, Michael K. Synthesis of Gala(1,3)Gal?(1,4)GlcNAca-, Gal?(1,4)GlcNAca- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease. Glycobiology. 2016 Jan; 26(1):39-50.
Score: 0.139
-
Ashmus RA, Schocker NS, Cordero-Mendoza Y, Marques AF, Monroy EY, Pardo A, Izquierdo L, G?llego M, Gascon J, Almeida IC, Michael K. Potential use of synthetic a-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease. Org Biomol Chem. 2013 Sep 14; 11(34):5579-83.
Score: 0.121
-
Zhou D, Levery SB, Hsu FF, Wang PG, Teneberg S, Almeida IC, Li Y, Xu H, Wang LX, Xia C, Ibrahim NK, Michael K. Immunologic mapping of glycomes: implications for cancer diagnosis and therapy. Front Biosci (Schol Ed). 2011 06 01; 3(4):1520-32.
Score: 0.103
-
Subramaniam KS, Austin V, Schocker NS, Montoya AL, Anderson MS, Ashmus RA, Mesri M, Al-Salem W, Almeida IC, Michael K, Acosta-Serrano A. Anti-a-Gal antibodies detected by novel neoglycoproteins as a diagnostic tool for Old World cutaneous leishmaniasis caused by Leishmania major. Parasitology. 2018 11; 145(13):1758-1764.
Score: 0.042
-
Iniguez E, Schocker NS, Subramaniam K, Portillo S, Montoya AL, Al-Salem WS, Torres CL, Rodriguez F, Moreira OC, Acosta-Serrano A, Michael K, Almeida IC, Maldonado RA. An a-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major. PLoS Negl Trop Dis. 2017 Oct; 11(10):e0006039.
Score: 0.040
-
Zheng X, Zhang X, Schocker NS, Renslow RS, Orton DJ, Khamsi J, Ashmus RA, Almeida IC, Tang K, Costello CE, Smith RD, Michael K, Baker ES. Enhancing glycan isomer separations with metal ions and positive and negative polarity ion mobility spectrometry-mass spectrometry analyses. Anal Bioanal Chem. 2017 Jan; 409(2):467-476.
Score: 0.037
-
Song W, Delyria ES, Chen J, Huang W, Lee JS, Mittendorf EA, Ibrahim N, Radvanyi LG, Li Y, Lu H, Xu H, Shi Y, Wang LX, Ross JA, Rodrigues SP, Almeida IC, Yang X, Qu J, Schocker NS, Michael K, Zhou D. MUC1 glycopeptide epitopes predicted by computational glycomics. Int J Oncol. 2012 Dec; 41(6):1977-84.
Score: 0.028